mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.6 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |